Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants

Jianbo Wu,Zhenguo Chen,Yidan Gao,Zegen Wang,Jiarong Wang,Bing-Yu Chiang,Yunjiao Zhou,Yuru Han,Wuqiang Zhan,Minxiang Xie,Weiyu Jiang,Xiang Zhang,Aihua Hao,Anqi Xia,Jiaying He,Song Xue,Fan Wu,Bin Wang,Lunan Zhang,Lei Sun,Qiao Wang,Christian T. Mayer
DOI: https://doi.org/10.1016/j.celrep.2023.112503
IF: 8.8
2023-05-13
Cell Reports
Abstract:Wu et al. identify that XG005, but not its family members, is a potent and broad SARS-CoV-2 neutralizer and exhibits a high therapeutic efficacy. Structural analysis identifies the key residues of XG005. This provides a natural example to show the importance of somatic hypermutation for SARS-CoV-2 neutralization breadth and potency.
cell biology
What problem does this paper attempt to address?